NO20032059L - Peroksisomproliferatoraktiverte reseptor alfa-agonister - Google Patents

Peroksisomproliferatoraktiverte reseptor alfa-agonister

Info

Publication number: NO20032059L
Authority: NO; Norway
Prior art keywords: activated receptor; receptor alpha; peroxisome proliferator; alpha agonists; agonists
Prior art date: 2000-11-10

Application number

NO20032059A

Other languages

English (en)

Norwegian (no)

Other versions

NO20032059D0 (no

Inventor

Nathan Bryan Mantlo

Ivan Collado Cano

Samuel James Dominianni

Jr Garret Jay Etgen

Cristina Garcia-Paredes

Richard Duane Johnston

Michael Edward Letourneau

Michael John Martinelli

Daniel Ray Mayhugh

Ashraf Saeed

Richard Craig Thompson

Xiadong Wang

David Scott Coffey

Christopher Randall Schmid

Jeffrey Thomas Vicenzi

Yanping Xu

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-10

Filing date

2003-05-08

Publication date

2003-06-24

2003-05-08 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2003-05-08 Publication of NO20032059D0 publication Critical patent/NO20032059D0/no

2003-06-24 Publication of NO20032059L publication Critical patent/NO20032059L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/22—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having nitrogen atoms of amidino groups further bound to nitrogen atoms, e.g. hydrazidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/02—Compounds containing any of the groups, e.g. carbazates
- C07C281/04—Compounds containing any of the groups, e.g. carbazates the other nitrogen atom being further doubly-bound to a carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cultivation Of Plants (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20032059A 2000-11-10 2003-05-08 Peroksisomproliferatoraktiverte reseptor alfa-agonister NO20032059L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US24731700P	2000-11-10	2000-11-10
PCT/US2001/042928 WO2002038553A2 (fr)	2000-11-10	2001-11-09	Agonistes de recepteurs alpha actives de la proliferation des peroxysomes

Publications (2)

Publication Number	Publication Date
NO20032059D0 NO20032059D0 (no)	2003-05-08
NO20032059L true NO20032059L (no)	2003-06-24

Family

ID=22934453

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20032059A NO20032059L (no)	2000-11-10	2003-05-08	Peroksisomproliferatoraktiverte reseptor alfa-agonister

Country Status (34)

Country	Link
US (3)	US7304062B2 (fr)
EP (1)	EP1335908B1 (fr)
JP (1)	JP4243101B2 (fr)
KR (1)	KR100839705B1 (fr)
CN (1)	CN1479728A (fr)
AR (1)	AR031305A1 (fr)
AT (1)	ATE386026T1 (fr)
AU (3)	AU2859202A (fr)
BR (1)	BR0114986A (fr)
CA (1)	CA2421154A1 (fr)
CY (1)	CY1107388T1 (fr)
CZ (1)	CZ20031283A3 (fr)
DE (1)	DE60132799T2 (fr)
DK (1)	DK1335908T3 (fr)
EA (1)	EA006920B1 (fr)
EC (1)	ECSP034595A (fr)
ES (1)	ES2300378T3 (fr)
HR (1)	HRP20030365A2 (fr)
HU (1)	HUP0301655A2 (fr)
IL (2)	IL154840A0 (fr)
MX (1)	MXPA03004141A (fr)
MY (1)	MY157884A (fr)
NO (1)	NO20032059L (fr)
NZ (1)	NZ524569A (fr)
PE (1)	PE20020693A1 (fr)
PL (1)	PL362692A1 (fr)
PT (1)	PT1335908E (fr)
SI (1)	SI1335908T1 (fr)
SK (1)	SK5412003A3 (fr)
SV (1)	SV2003000727A (fr)
TW (1)	TW200716572A (fr)
UA (1)	UA82048C2 (fr)
WO (1)	WO2002038553A2 (fr)
ZA (1)	ZA200302517B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003043997A1 (fr) *	2001-11-15	2003-05-30	Eli Lilly And Company	Agonistes de recepteurs alpha actives de la proliferation des peroxysomes
GB0314079D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
CN1662487A (zh)	2002-06-19	2005-08-31	伊莱利利公司	酰胺连接基过氧化物酶体增殖物激活受体调节剂
TW200505441A (en)	2003-03-24	2005-02-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitorsⅠ
FR2866339B1 (fr) *	2004-02-18	2006-05-05	Pf Medicament	Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
JP4675959B2 (ja) *	2004-07-27	2011-04-27	エフ．ホフマン−ラロシュアーゲー	非ヌクレオシド逆転写酵素阻害剤としてのベンジルトリアゾロン化合物
KR100803481B1 (ko) *	2004-07-27	2008-02-14	에프. 호프만-라 로슈 아게	비-뉴클레오사이드 역전사효소 억제제로서의벤질트라이아졸론 화합물
US8293778B2 (en)	2004-07-27	2012-10-23	Roche Palo Alto Llc	Heterocyclic antiviral compounds
NZ552501A (en) *	2004-08-11	2010-03-26	Kyorin Seiyaku Kk	Novel cyclic aminobenzoic acid derivative
WO2006068199A1 (fr) *	2004-12-22	2006-06-29	Mochida Pharmaceutical Co., Ltd.	Dérivés de 3-oxy-1,2,4-triazole métaboliquement stables
DOP2006000018A (es) *	2005-01-28	2006-07-15	Lilly Co Eli	Formulaciones y regimen de dosificación para moduladores alfa de ppar
FR2882750B1 (fr) *	2005-03-03	2007-05-11	Pierre Fabre Medicament Sa	Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
CN101189231B (zh) *	2005-03-23	2011-05-18	杏林制药株式会社	环状氨基苯基链烷酸衍生物
CN101180280A (zh) *	2005-03-24	2008-05-14	弗·哈夫曼-拉罗切有限公司	作为杂环逆转录酶抑制剂的1,2,4-三唑-5-酮化合物
JP5225076B2 (ja) *	2006-04-27	2013-07-03	田辺三菱製薬株式会社	チアゾール環を含むカルボン酸誘導体の医薬用途
EP2129667A2 (fr) *	2007-02-23	2009-12-09	Eli Lilly And Company	Modulateurs du récepteur au facteur activé de prolifération des peroxysomes
JP2010522706A (ja)	2007-03-29	2010-07-08	エフ．ホフマン−ラロシュアーゲー	非ヌクレオシド逆転写酵素阻害剤
US8323360B2 (en) *	2008-06-30	2012-12-04	3M Innovative Properties Company	Method of crystallization
CN101643451B (zh) *	2008-08-07	2013-03-06	浙江海正药业股份有限公司	过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法
CN102300853A (zh)	2008-12-01	2011-12-28	田边三菱制药株式会社	含有噻唑环的羧酸衍生物及其药学用途
US20110167512A1 (en) *	2009-03-02	2011-07-07	Nunhems B.V.	Hybrid artichoke variety nun 4006 ar
US8575430B2 (en) *	2010-03-02	2013-11-05	Nunhems, B.V.	Hybrid artichoke variety NUN 4006 AR
DE102010001064A1 (de) *	2009-03-18	2010-09-23	Bayer Schering Pharma Aktiengesellschaft	Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
US20100245582A1 (en) *	2009-03-25	2010-09-30	Syclipse Technologies, Inc.	System and method of remote surveillance and applications therefor
US20130156720A1 (en)	2010-08-27	2013-06-20	Ironwood Pharmaceuticals, Inc.	Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US8648233B2 (en) *	2010-09-20	2014-02-11	Nunhems B.V.	Hybrid artichoke variety NUN 4021 AR
US8669420B2 (en)	2012-02-29	2014-03-11	Nunhems B.V.	Hybrid artichoke variety NUN 4060 AR
EP2822931B1 (fr) *	2012-03-09	2017-05-03	Inception 2, Inc.	Composés de triazolone et leurs utilisations
US9676754B2 (en) *	2012-12-20	2017-06-13	Inception 2, Inc.	Triazolone compounds and uses thereof
CN105579440A (zh) *	2013-09-06	2016-05-11	因森普深2公司	三唑酮化合物及其应用
RU177130U1 (ru) *	2017-11-29	2018-02-09	Владимир Алексеевич Коннов	Плита изоляционная облицовочная
JPWO2021205803A1 (fr)	2020-04-10	2021-10-14
CN112774869B (zh) *	2020-12-25	2022-09-16	厦门紫金矿冶技术有限公司	黄铁矿抑制剂及其制备和在铜铅锌多金属硫化矿中的应用
CN114853686B (zh) *	2021-08-23	2023-06-20	中国药科大学	三氮唑酮类化合物及其医药用途
CN115894379B (zh) *	2022-01-20	2025-06-27	哈尔滨三联药业股份有限公司	海因类化合物及其医药用途
CN114563394B (zh) *	2022-02-10	2025-03-11	湖南东方钪业股份有限公司	一种氟化钪中杂质含量的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2090283A1 (fr)	1992-02-28	1993-08-29	Nobuyuki Hamanaka	Derives de l'acide phenoxyacetique
US5641796A (en) *	1994-11-01	1997-06-24	Eli Lilly And Company	Oral hypoglycemic agents
DE19517505A1 (de)	1995-05-12	1996-11-14	Bayer Ag	Sulfonylamino(thio)carbonyltriazolin(thi)one mit Aryloxy- oder Arylthio-Substituenten
CA2229617A1 (fr)	1995-10-20	1997-05-01	Dr. Karl Thomae Gmbh	Heterocycles a 5 chainons; medicaments a base de ces composes; leur emploi et methodes pour les preparer
EP1028111B1 (fr)	1997-10-17	2004-05-12	Yamanouchi Pharmaceutical Co. Ltd.	Derives amides ou sels desdits derives
EP1073643B1 (fr) *	1998-04-23	2004-12-29	Dr. Reddy's Laboratories Ltd.	Nouveaux composes heterocycliques, leur utilisation en medecine, leur procede de preparation et compositions pharmaceutiques les contenant
GB9914977D0 (en)	1999-06-25	1999-08-25	Glaxo Group Ltd	Chemical compounds
PE20011010A1 (es)	1999-12-02	2001-10-18	Glaxo Group Ltd	Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
US6573287B2 (en)	2001-04-12	2003-06-03	Bristo-Myers Squibb Company	2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
USPP14578P2 (en) *	2002-09-23	2004-03-09	Plant Sciences, Inc.	Artichoke plant named ‘PS-MSC0003’

2001
- 2001-09-11 UA UA2003054187A patent/UA82048C2/uk unknown
- 2001-11-07 AR ARP010105214A patent/AR031305A1/es unknown
- 2001-11-08 TW TW095138799A patent/TW200716572A/zh unknown
- 2001-11-08 PE PE2001001108A patent/PE20020693A1/es not_active Application Discontinuation
- 2001-11-08 MY MYPI20015155A patent/MY157884A/en unknown
- 2001-11-09 KR KR1020037006301A patent/KR100839705B1/ko not_active Expired - Fee Related
- 2001-11-09 EA EA200300558A patent/EA006920B1/ru not_active IP Right Cessation
- 2001-11-09 AT AT01989704T patent/ATE386026T1/de not_active IP Right Cessation
- 2001-11-09 JP JP2002541088A patent/JP4243101B2/ja not_active Expired - Fee Related
- 2001-11-09 WO PCT/US2001/042928 patent/WO2002038553A2/fr not_active Ceased
- 2001-11-09 HR HR20030365A patent/HRP20030365A2/hr not_active Application Discontinuation
- 2001-11-09 SV SV2001000727A patent/SV2003000727A/es not_active Application Discontinuation
- 2001-11-09 US US10/415,673 patent/US7304062B2/en not_active Expired - Fee Related
- 2001-11-09 BR BR0114986-5A patent/BR0114986A/pt not_active IP Right Cessation
- 2001-11-09 AU AU2859202A patent/AU2859202A/xx active Pending
- 2001-11-09 EP EP01989704A patent/EP1335908B1/fr not_active Expired - Lifetime
- 2001-11-09 NZ NZ524569A patent/NZ524569A/en unknown
- 2001-11-09 CZ CZ20031283A patent/CZ20031283A3/cs unknown
- 2001-11-09 HU HU0301655A patent/HUP0301655A2/hu unknown
- 2001-11-09 IL IL15484001A patent/IL154840A0/xx unknown
- 2001-11-09 DK DK01989704T patent/DK1335908T3/da active
- 2001-11-09 AU AU2002228592A patent/AU2002228592B8/en not_active Ceased
- 2001-11-09 CA CA002421154A patent/CA2421154A1/fr not_active Abandoned
- 2001-11-09 ES ES01989704T patent/ES2300378T3/es not_active Expired - Lifetime
- 2001-11-09 PL PL01362692A patent/PL362692A1/xx unknown
- 2001-11-09 SI SI200130828T patent/SI1335908T1/sl unknown
- 2001-11-09 MX MXPA03004141A patent/MXPA03004141A/es active IP Right Grant
- 2001-11-09 PT PT01989704T patent/PT1335908E/pt unknown
- 2001-11-09 DE DE60132799T patent/DE60132799T2/de not_active Expired - Fee Related
- 2001-11-09 CN CNA018185878A patent/CN1479728A/zh active Pending
- 2001-11-09 SK SK541-2003A patent/SK5412003A3/sk not_active Application Discontinuation
2003
- 2003-03-10 IL IL154840A patent/IL154840A/en active IP Right Grant
- 2003-03-31 ZA ZA200302517A patent/ZA200302517B/en unknown
- 2003-05-08 NO NO20032059A patent/NO20032059L/no unknown
- 2003-05-08 EC EC2003004595A patent/ECSP034595A/es unknown
2006
- 2006-06-29 AU AU2006202811A patent/AU2006202811A1/en not_active Abandoned
2007
- 2007-07-26 US US11/828,446 patent/US20090062358A1/en not_active Abandoned
2008
- 2008-04-10 CY CY20081100391T patent/CY1107388T1/el unknown
- 2008-06-27 US US12/215,466 patent/US7868225B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO20032059D0 (no)	2003-05-08
SI1335908T1 (sl)	2008-08-31
PE20020693A1 (es)	2002-08-05
DE60132799T2 (de)	2009-03-19
HK1058790A1 (en)	2004-06-04
EA006920B1 (ru)	2006-04-28
SK5412003A3 (en)	2004-01-08
WO2002038553A3 (fr)	2003-05-01
MXPA03004141A (es)	2003-08-19
AU2859202A (en)	2002-05-21
HUP0301655A2 (hu)	2003-12-29
ECSP034595A (es)	2003-06-25
SV2003000727A (es)	2003-01-13
US7868225B2 (en)	2011-01-11
DE60132799D1 (de)	2008-03-27
AU2002228592B2 (en)	2006-04-27
DK1335908T3 (da)	2008-06-02
EA200300558A1 (ru)	2004-02-26
KR20030048133A (ko)	2003-06-18
CA2421154A1 (fr)	2002-05-16
EP1335908B1 (fr)	2008-02-13
CY1107388T1 (el)	2012-12-19
EP1335908A2 (fr)	2003-08-20
TW200716572A (en)	2007-05-01
JP4243101B2 (ja)	2009-03-25
US20090062358A1 (en)	2009-03-05
IL154840A0 (en)	2003-10-31
US20040102500A1 (en)	2004-05-27
PT1335908E (pt)	2008-05-08
PL362692A1 (en)	2004-11-02
IL154840A (en)	2009-09-22
HRP20030365A2 (en)	2003-08-31
MY157884A (en)	2016-08-01
KR100839705B1 (ko)	2008-06-19
BR0114986A (pt)	2003-09-23
CN1479728A (zh)	2004-03-03
AU2002228592B8 (en)	2006-08-24
NZ524569A (en)	2006-05-26
UA82048C2 (uk)	2008-03-11
AR031305A1 (es)	2003-09-17
CZ20031283A3 (cs)	2003-09-17
ES2300378T3 (es)	2008-06-16
ATE386026T1 (de)	2008-03-15
WO2002038553A2 (fr)	2002-05-16
US20090044299A1 (en)	2009-02-12
ZA200302517B (en)	2004-06-30
AU2006202811A1 (en)	2006-07-20
US7304062B2 (en)	2007-12-04
JP2004513166A (ja)	2004-04-30

Publication	Publication Date	Title
NO20032059L (no)	2003-06-24	Peroksisomproliferatoraktiverte reseptor alfa-agonister
NO20042737L (no)	2004-08-17	Peroksisomproliferatoraktiverte receptoragonister
DK1446379T3 (da)	2009-07-27	Arylanilin-beta2-adrenergiske receptoragonister
EE200300191A (et)	2003-10-15	Alfa-arüül-etanoolamiinid ja nende kasutamine beeta-3 adrenergiliste retseptorite agonistidena
DK1330611T3 (da)	2005-01-17	Teleskoparm
NO20025115D0 (no)	2002-10-24	Muskarin agonister
ATE363466T1 (de)	2007-06-15	Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
NO20030098L (no)	2003-01-09	<Beta>3 adrenergiske agonister
DE60205100D1 (de)	2005-08-25	DIHYDRO-BENZO (b) (1,4) DIAZEPIN-2-ON-DERIVATE ALS MGLUR2 ANTAGONISTEN
DE50005580D1 (de)	2004-04-15	Puffervorrichtung
DK1189916T3 (da)	2004-03-22	N-pyrazol A 2A-receptoragonister
ATE287883T1 (de)	2005-02-15	Dihydro-benzo(b)(1,4)diazepin-2-on-derivate als mglur2 antagonisten
NO20034497L (no)	2003-10-27	Somatostatin agonister
EE200200204A (et)	2003-04-15	Asendatud bensimidasooli preparaat
DK1464641T3 (da)	2008-08-18	4-phenylpiperazinyl-, -piperidinyl- og -tetrahydropyridylderivater som dopamin-D4-antagonister
ITMI20000749A0 (it)	2000-04-07	Dispositivo di spostamento assiale
AU2002347985A1 (en)	2003-06-10	Peroxisome proliferator activated receptor alpha agonists
DE60142038D1 (de)	2010-06-17	Aktivatoren des peroxisome proliferator-activated rezeptors
ID30056A (id)	2001-11-01	Agonis-agonis 5-htif
DE60100450D1 (de)	2003-08-14	Multiprozessorschnittstelle
DE50001813D1 (de)	2003-05-22	Substituierte benzoxazole
FR2813902B1 (fr)	2002-10-31	Supports articules
NO20000146L (no)	2000-07-13	Arbeidsinnretning
HK1071563A (en)	2005-07-22	Peroxisome proliferator activated receptor agonists
ITRE20010019A0 (it)	2001-03-01	Tampone ceramico perfezionato